期刊文献+

纳米粒子介导反义mTOR基因转染抑制移植静脉内膜增生 被引量:2

The effect of antisense mTOR gene mediated by nanoparticles on neointimal formation in vein graft in rats
下载PDF
导出
摘要 目的观察以纳米粒子为载体的外源性反义雷帕霉素靶蛋白(mTOR)基因局部转染对移植静脉内膜增生的影响。方法应用聚乳酸聚乙醇酸共聚物(PLGA)和聚乙烯醇(PVA)包载mTOR基因,制备纳米级粒子混合物。建立自体静脉移植模型72只,随机分成转基因组(转染以纳米粒子为载体的反义mTOR基因),空载体组(单纯转染纳米粒子包载的空载体)和对照组(不予特殊处理)。分别于术后3,7,14,28d取材。检测mTOR基因的mRNA及蛋白产物表达,以及血管平滑肌细胞(VSMC)凋亡的动态变化。结果转基因组内膜中mTOR基因的mRNA及蛋白产物表达较其他两组明显减少(P<0.05);转基因组内膜增生厚度于7,14,28d较其他组明显减少(P<0.01);转基因组凋亡细胞较其他组明显增高(P<0.05)。结论纳米粒子可以作为转基因载体。反义mTOR基因的表达能有效抑制自体移植静脉内膜的增生及促进VSMC凋亡。 Objective To study the effect of antisense mTOR gene transfection mediated by nanoparticles ( NP ) on intimal perliferation after vein grafting. Methods Nanoparticle antisense roTOR gene complex was prepared with PLGA and PVA. Autogenous vein graft model was established in 72 rats by transplanting internal branch of jugular vein to carotid artery. Three groups were studied : ( 1 ) antisense mTOR group, antisense mTOR gene mediated by NP was transfected into the veins before anastomosis. (2) Empty vector group, the vein was transfected by empty vector mediated by NP. (3) Control group, no transfection. The grafted veins were harvested 3 days, 1 week, 2 weeks and 4 weeks after operation, respectively. The exogenous mTOR mRNA and protein expression were determined and intimal hyperplasia ( IH ) was observed. The presence of apoptotic VSMC was also detected. Results Antisense mTOR gene transfection mediated by nanoparticle complex inhibited the mRNA and protein expression of mTOR gene ( P 〈 0.05 ) , and the IH was inhibited in the vein graft especially during 7 d - 28 d ( P 〈 0. 01 ). Conclusions Nanoparticle is an effective gene transfecting carrier, and antisense mTOR gene expression can prevent the IH and promote apoptosis after vein grafting.
出处 《中国普通外科杂志》 CAS CSCD 2007年第6期570-573,共4页 China Journal of General Surgery
基金 国家自然科学基金资助项目(30400435 30672048) 辽宁省博士启动基金资助项目(20041053)
关键词 雷帕霉素靶蛋白 内膜增生 纳米粒子 转染 基因表达 mTOR Intimal Hyperplasia Nanoparticle Transfection Gene Expression
  • 相关文献

参考文献6

二级参考文献12

  • 1Schimmer AD.Inhibitor of apoptosis proteins:translating basic knowledge into clinical practice[J].Cancer Res,2004,64(20):7183 -7190.
  • 2SambrookJ FritschEF ManiatisT 金冬雁 黎孟枫 译.克隆化基因所表达蛋白质的检测与分析(A)[A].金冬雁,黎孟枫,译.分子克隆实验指南[M].(第2版)[C].北京:科学出版社,1992.852-898.
  • 3Yang D,Welm A,Bishop JM.Cell division and cell survival in the absence of survivin[J].Proc Natl Acad Sci USA,2004,101(42):15100-15105.
  • 4Dzau V,Braun-Dullaeus RC,Sedding D.Vascular proliferation and atherosclerosis:New perspectives and therapeutic strategies[J].Nature Medicine,2002,8(11):1249-1256.
  • 5Martin RB,Stephen M,Schwart M.Antisense therapy for angioplasty restenosis[J].Circulation,1995,92 (36):1981-1986.
  • 6Moses JW,Leon MB,Popma JJ,et al.Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery.N Engl J Med,2003,349:1315-1323.
  • 7Dzau VJ,Braun-Dullaeus RC,Sedding DG.Vascular proliferation and atherosclerosis:new perspectives and therapeutic strategies.Nature Med,2002,8:1249-1256.
  • 8冯勇,段志泉,胡海地,吕庆杰,裴庆双.移植静脉平滑肌细胞凋亡及相关基因表达与增殖关系的动态研究[J].中华医学杂志,1999,79(1):15-18. 被引量:8
  • 9胡新华,张强,孙达欣,段佩琰,王新文,段志泉.核转录因子κB及其抑制基因在自体移植静脉中的表达[J].中华医学杂志,2002,82(22):1546-1549. 被引量:22
  • 10胡新华,张强,段佩琰,王新文,辛世杰,段志泉.细胞间粘附分子-1在自体移植静脉中表达的动态变化[J].中华实验外科杂志,2003,20(6):529-531. 被引量:5

共引文献16

同被引文献27

  • 1刘程伟,胡新华,杨军,杨德华,张强,张志深,段志泉,辛世杰.Egr-1,PDGF-B,TGF-β_1在自体移植静脉中的实验研究[J].中国普通外科杂志,2005,14(12):900-904. 被引量:3
  • 2胡新华,张强,杨军,刘程伟,张志深.反义mTOR逆转录病毒载体对血管平滑肌细胞增殖的抑制作用[J].中国普通外科杂志,2006,15(12):912-916. 被引量:4
  • 3McCormack MC, Nguyen JT, Tatlidede HS, et al. Ischemic preconditioning of skeletal muscle mitigates remote injury and mortality[J]. J Surg Res, 2008, 148(1) : 24-30.
  • 4Zhao ZQ, Corvera JS, Halkos ME, et al. Inhibition of myocardial injury by ischemic postconditioning during reperfusion : comparison with ischemic preconditioning [ J ]. Am J Physiol Heart Circ Physiol, 2003, 285(2) : H579 -588.
  • 5McAllister SE, Ashrafpour H, Cahoon N, et al. Postconditioning for salvage of ischemic skeletal muscle from reperfusion injury: efficacy and mechanism [ J ]. Am J Physiol Regul Integr Comp Physiol, 2008, 295(2) : R681 -689.
  • 6Paillard M, Gomez L, Augeul L, et al. Postconditioning inhibits mPTP opening independent of oxidative phosphorylation and membrane potential [ J ] . J Mol Cell Cardiol, 2009 , 46 (6) : 902-909.
  • 7Mykytenko J, Reeves JG, Kin H, et al. Persistent beneficial effect of posteonditioning against infarct size : role of mitochondrial K ( ATP ) eb ls during reperfusion [ J ]. Basic Res Cardiol, 2008, 103(5) : 472 -484.
  • 8Lim SY, Davidson SM, Hausenloy D J, et al. Preconditioning and postconditioning : the essential role of the mitochondrial permeability transition pore [ J ] . Cardiovasc Res, 2007, 75(3) : 530-535.
  • 9Bopassa JC, Ferrera R, Gateau-Roesch O, et al. PI 3-kinase regulates the mitochondrial transition pore in controlled reperfusion and postconditioning[J].Cardiovasc Res, 2006,69(1): 178-185.
  • 10Yong QC, Lee SW, Foo CS, et al. Endogenous hydrogen sulphide mediates the cardioprotection induced by ischemic postconditioning [ J ]. Am J Physiol Heart Circ Physiol, 2008, 295(3) : H1330-H1340.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部